Esdras Marques Lins
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Esdras Marques Lins has a total of 149 co-authors. Here are the top co-authors by number of shared publications:
- Emmanuelle Tenório Albuquerque Madruga Godoi
Universidade Federal de Pernambuco, Recife, PE, Brazil
9 shared publications - Fernanda Appolonio Rocha
Universidade Federal de Pernambuco, Brasil
8 shared publications Rebecca Paes de Andrade Souza Caldas
Department of Vascular Surgery/HC/EBSERH, Federal University of Pernambuco, Recife, Pernambuco, Brazil
6 shared publicationsGabriela de Oliveira Buril
5 shared publicationsEmmanuelle Tenório Albuquerque Godoi Berenguer de Barros e Silva
Post-Graduated Program in Surgery, Federal University of Pernambuco, Recife, Pernambuco, Brazil
4 shared publications- Simone Cristina Soares Brandão
Universidade Federal de Pernambuco
4 shared publications
Latest Publications
- Open Access
- 27 October 2026
- Published by Elsevier in JVS-Vascular Insights
Resistance Index And The Risk Of Major Amputation In Patients With Chronic Limb-Threatening Ischaemia Undergoing Lower Limb Revascularization
- 27 October 2026
- Published by Elsevier in JVS-Vascular Insights
Open AccessResistance Index And The Risk Of Major Amputation In Patients With Chronic Limb-Threatening Ischaemia Undergoing Lower Limb Revascularization
- Open Access
- 19 August 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (10) , 5164-5172
Triglyceride-to-HDL Cholesterol Ratio is Associated with Hepatic Steatosis but not Fibrosis in Patients with Severe Obesity: A Cross-Sectional Study
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent among individuals with severe obesity. The triglyceride-to-high-density lipoprotein cholesterol ratio (TG/HDL-C) is an accessible surrogate marker of insulin resistance, but its association with hepatic steatosis and fibrosis in candidates for metabolic and bariatric surgery remains incompletely defined. Methods: This retrospective cross-sectional study included 99 patients undergoing preoperative evaluation for metabolic and bariatric surgery between 2020 and 2024. Hepatic steatosis was assessed by ultrasonography and liver fibrosis by elastography. Associations with TG/HDL-C were examined using categorical analyses and multivariable logistic regression. Because diabetes perfectly predicted hepatic steatosis, Firth penalized logistic regression was used for the primary adjusted analysis. Results: The cohort included 61 women (61.6%), with a mean age of 37.0 ± 9.8 years and body mass index of 40.4 ± 4.2 kg/m². Hepatic steatosis was present in 81 of 99 patients (81.8%), whereas fibrosis was identified in 35 of 98 patients with evaluable elastography (35.7%). Higher TG/HDL-C categories were associated with hepatic steatosis ( p = 0.0016). After adjustment, each unit increase in TG/HDL-C was associated with higher odds of steatosis (adjusted odds ratio, 2.23; 95% CI, 1.22–4.08; p = 0.0090). TG/HDL-C showed moderate discrimination for steatosis (area under the curve, 0.763; 95% confidence interval, 0.632–0.868), with an exploratory optimal threshold of 2.17 (79.0% sensitivity and 66.7% specificity). In contrast, TG/HDL-C was not associated with fibrosis after adjustment (adjusted odds ratio, 0.84; 95% confidence interval, 0.63–1.10; p = 0.209) and showed no discriminatory ability for fibrosis (area under the curve, 0.494). Conclusions: TG/HDL-C was independently associated with ultrasonographically detected hepatic steatosis and showed moderate discriminatory performance in patients with severe obesity undergoing evaluation for metabolic and bariatric surgery. However, it was not associated with fibrosis assessed by elastography. These findings support TG/HDL-C as a potential low-cost adjunct for identifying steatosis, but not as a substitute for fibrosis-specific assessment.
- 19 August 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (10) , 5164-5172
Open AccessTriglyceride-to-HDL Cholesterol Ratio is Associated with Hepatic Steatosis but not Fibrosis in Patients with Severe Obesity: A Cross-Sectional Study
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent among individuals with severe obesity. The triglyceride-to-high-density lipoprotein cholesterol ratio (TG/HDL-C) is an accessible surrogate marker of insulin resistance, but its association with hepatic steatosis and fibrosis in candidates for metabolic and bariatric surgery remains incompletely defined. Methods: This retrospective cross-sectional study included 99 patients undergoing preoperative evaluation for metabolic and bariatric surgery between 2020 and 2024. Hepatic steatosis was assessed by ultrasonography and liver fibrosis by elastography. Associations with TG/HDL-C were examined using categorical analyses and multivariable logistic regression. Because diabetes perfectly predicted hepatic steatosis, Firth penalized logistic regression was used for the primary adjusted analysis. Results: The cohort included 61 women (61.6%), with a mean age of 37.0 ± 9.8 years and body mass index of 40.4 ± 4.2 kg/m². Hepatic steatosis was present in 81 of 99 patients (81.8%), whereas fibrosis was identified in 35 of 98 patients with evaluable elastography (35.7%). Higher TG/HDL-C categories were associated with hepatic steatosis ( p = 0.0016). After adjustment, each unit increase in TG/HDL-C was associated with higher odds of steatosis (adjusted odds ratio, 2.23; 95% CI, 1.22–4.08; p = 0.0090). TG/HDL-C showed moderate discrimination for steatosis (area under the curve, 0.763; 95% confidence interval, 0.632–0.868), with an exploratory optimal threshold of 2.17 (79.0% sensitivity and 66.7% specificity). In contrast, TG/HDL-C was not associated with fibrosis after adjustment (adjusted odds ratio, 0.84; 95% confidence interval, 0.63–1.10; p = 0.209) and showed no discriminatory ability for fibrosis (area under the curve, 0.494). Conclusions: TG/HDL-C was independently associated with ultrasonographically detected hepatic steatosis and showed moderate discriminatory performance in patients with severe obesity undergoing evaluation for metabolic and bariatric surgery. However, it was not associated with fibrosis assessed by elastography. These findings support TG/HDL-C as a potential low-cost adjunct for identifying steatosis, but not as a substitute for fibrosis-specific assessment.
- Open Access
- 1 April 2026
- Published by Elsevier in JVS-Vascular Insights
- Vol. 4
Surgical reconstruction in cephalic vein arch stenosis in patients with brachiocephalic arteriovenous fistulas: A case series study
- 1 April 2026
- Published by Elsevier in JVS-Vascular Insights
- Vol. 4
Open AccessSurgical reconstruction in cephalic vein arch stenosis in patients with brachiocephalic arteriovenous fistulas: A case series study
- Open Access
- 21 August 2025
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 13 (6) , 102302
Application of bacterial cellulose film as a wound dressing in varicose vein surgery: A randomized clinical trial
- 21 August 2025
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 13 (6) , 102302
Open AccessApplication of bacterial cellulose film as a wound dressing in varicose vein surgery: A randomized clinical trial
- 9 May 2025
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 120, 181-189
The Resistance Index Used to Evaluate Plantar Arch Anatomy in Patients with Chronic Limb-Threatening Ischemia
- 9 May 2025
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 120, 181-189
The Resistance Index Used to Evaluate Plantar Arch Anatomy in Patients with Chronic Limb-Threatening Ischemia
- 23 March 2025
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 27 (1) , 162-168
Retrospective study of vacuum aspiration mechanical thrombectomy device in the treatment of arteriovenous fistula thrombosis and patient is on hemodialysis
Objective: To evaluate the use of the device of mechanical thrombectomy aspiration in the salvage of the fistula for hemodialysis access (HD) with acute thrombosis. Method: The study model used was a retrospective cohort in which 35 patients, who underwent 44 percutaneus thrombectomy in a tertiary hospital between October 2018 and March 2020, were evaluated. The surgical time of the thrombectomy, the technical success (TS) and the clinical success (CS) were evaluated, as well as the occurrence of surgical complications. Additional adjunct therapy, such balloon angioplasty or thrombolytic therapy when performed was not evaluated. Results: Among the 35 evaluated patients, 24 (66.8%) were male. In 33 of these cases (75%), the fistula used an autologous vein (AV fistula). The average thrombectomy time was 20.2 min and median was 15 min, with a difference between the AV fistula and synthetic graft (Graft) ( p = 0.001), being shorter in the Graft. The TS rate was of 86.4% and the CS rate was of 84.1% with no statistical difference between the groups. The rate of surgical complications was of 13.6%. Blood loss in most cases ranged from 100 to 300 ml in the majority of the cases. Conclusion: The Device showed a short operation time in its use, a high rate of technical success and clinical success, as well as a similar rate of immediate surgical complications found in the literature.
- 23 March 2025
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 27 (1) , 162-168
Retrospective study of vacuum aspiration mechanical thrombectomy device in the treatment of arteriovenous fistula thrombosis and patient is on hemodialysis
Objective: To evaluate the use of the device of mechanical thrombectomy aspiration in the salvage of the fistula for hemodialysis access (HD) with acute thrombosis. Method: The study model used was a retrospective cohort in which 35 patients, who underwent 44 percutaneus thrombectomy in a tertiary hospital between October 2018 and March 2020, were evaluated. The surgical time of the thrombectomy, the technical success (TS) and the clinical success (CS) were evaluated, as well as the occurrence of surgical complications. Additional adjunct therapy, such balloon angioplasty or thrombolytic therapy when performed was not evaluated. Results: Among the 35 evaluated patients, 24 (66.8%) were male. In 33 of these cases (75%), the fistula used an autologous vein (AV fistula). The average thrombectomy time was 20.2 min and median was 15 min, with a difference between the AV fistula and synthetic graft (Graft) ( p = 0.001), being shorter in the Graft. The TS rate was of 86.4% and the CS rate was of 84.1% with no statistical difference between the groups. The rate of surgical complications was of 13.6%. Blood loss in most cases ranged from 100 to 300 ml in the majority of the cases. Conclusion: The Device showed a short operation time in its use, a high rate of technical success and clinical success, as well as a similar rate of immediate surgical complications found in the literature.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Escola de Enfermagem da USP
- Vol. 59, e20250121
Frailty and arteriovenous fistula patency in elderly hemodialysis patients: a retrospective cohort study
To evaluate the correlation between frailty and AVF patency type in elderly patients in HD. This retrospective cohort study evaluated 89 patients from April 2019 to June 2022. The following data were analyzed: 1) Patient characteristics according to the Clinical Frailty Scale (CFS), 2) Charlson score, 3) AVF site (radiocephalic, brachiocephalic, basilic), 4) Patency type (primary and assisted), 5) Mortality. This study was approved by the Ethics Committee of the Oswaldo Cruz University Hospital - University of Pernambuco, under registration no. 4.487.269. Among the 89 patients (age = 70 ± 8, 64% female, 36% frail), 42 (47%) had assisted AVF patency, with 26 (62%) being frail. A positive correlation was found between assisted patency and frailty (p = 0.043). During follow-up (548 to 938 days), 33 (37.1%) patients died, with frail patients showing a higher prevalence of CKD and a higher frequency of assisted patency. Assisted AVF patency was the most common type among frail elderly patients on hemodialysis. Frailty assessment may be integrated into the clinical evaluation protocol conducted by nurses at HD centers.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Escola de Enfermagem da USP
- Vol. 59, e20250121
Open AccessFrailty and arteriovenous fistula patency in elderly hemodialysis patients: a retrospective cohort study
To evaluate the correlation between frailty and AVF patency type in elderly patients in HD. This retrospective cohort study evaluated 89 patients from April 2019 to June 2022. The following data were analyzed: 1) Patient characteristics according to the Clinical Frailty Scale (CFS), 2) Charlson score, 3) AVF site (radiocephalic, brachiocephalic, basilic), 4) Patency type (primary and assisted), 5) Mortality. This study was approved by the Ethics Committee of the Oswaldo Cruz University Hospital - University of Pernambuco, under registration no. 4.487.269. Among the 89 patients (age = 70 ± 8, 64% female, 36% frail), 42 (47%) had assisted AVF patency, with 26 (62%) being frail. A positive correlation was found between assisted patency and frailty (p = 0.043). During follow-up (548 to 938 days), 33 (37.1%) patients died, with frail patients showing a higher prevalence of CKD and a higher frequency of assisted patency. Assisted AVF patency was the most common type among frail elderly patients on hemodialysis. Frailty assessment may be integrated into the clinical evaluation protocol conducted by nurses at HD centers.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Escola de Enfermagem da USP
- Vol. 59, e20240213
Clinical management and outcomes in severe COVID-19: acute respiratory distress syndrome across two waves
Objective: Analyze changes in epidemiological and prognostic factors, clinical management and the evolutionary impact of these variables on in-hospital outcomes by comparing the first two waves of Acute Respiratory Distress Syndrome (ARDS) due COVID-19 in a university center in Northeastern Brazil
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Escola de Enfermagem da USP
- Vol. 59, e20240213
Open AccessClinical management and outcomes in severe COVID-19: acute respiratory distress syndrome across two waves
Objective: Analyze changes in epidemiological and prognostic factors, clinical management and the evolutionary impact of these variables on in-hospital outcomes by comparing the first two waves of Acute Respiratory Distress Syndrome (ARDS) due COVID-19 in a university center in Northeastern Brazil
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Escola de Enfermagem da USP
- Vol. 59, e20240213
Gestión clínica y resultados en casos graves de COVID-19: síndrome de distrés respiratorio agudo en dos olas
Objetivo: Analizar los cambios en los factores epidemiológicos y en los pronósticos, el manejo clínico y el impacto evolutivo de estas variables en los resultados hospitalarios, comparando las dos primeras oleadas de Síndrome de Distrés Respiratorio Agudo (SDRA) por COVID-19 en un centro universitario del nordeste de Brasil.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Escola de Enfermagem da USP
- Vol. 59, e20240213
Open AccessGestión clínica y resultados en casos graves de COVID-19: síndrome de distrés respiratorio agudo en dos olas
Objetivo: Analizar los cambios en los factores epidemiológicos y en los pronósticos, el manejo clínico y el impacto evolutivo de estas variables en los resultados hospitalarios, comparando las dos primeras oleadas de Síndrome de Distrés Respiratorio Agudo (SDRA) por COVID-19 en un centro universitario del nordeste de Brasil.
- 23 November 2024
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 111, 360-366
Resistance Index as a Prognostic Factor for Patency in Distal Lower Limb Arterial Revascularization
- 23 November 2024
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 111, 360-366
Resistance Index as a Prognostic Factor for Patency in Distal Lower Limb Arterial Revascularization